反応式
[CH2:1]([O:3][C:4](=[O:29])[CH2:5][CH2:6][NH:7][C:8]([NH:10][C:11]1[S:12][C:13]([C:17]2[CH:22]=[CH:21][N:20]=[C:19](N3CCOCC3)[CH:18]=2)=[C:14]([CH3:16])[N:15]=1)=[O:9])[CH3:2].C(OC(=O)CNC(NC1SC(C2C=CN=CC=2)=C(C)N=1)=O)C>>[CH2:1]([O:3][C:4](=[O:29])[CH2:5][CH2:6][NH:7][C:8]([NH:10][C:11]1[S:12][C:13]([C:17]2[CH:18]=[CH:19][N:20]=[CH:21][CH:22]=2)=[C:14]([CH3:16])[N:15]=1)=[O:9])[CH3:2]参加物
3
実験手順
This compound is prepared by an analogous procedure to 3-{3-[4-Methyl-5-(2-morpholin-4-yl-pyridin-4-yl)-thiazol-2-yl]-ureido}-propionic acid ethyl ester (Example 14) by replacing 4-Methyl-5-(2-morpholin-4-yl-pyridin-4-yl)-thiazol-2-ylamine hydrobromide (13b) with 4-methyl-5-pyridin-4-yl-thiazol-2-ylamine (see Example 16 for reference).
出典と根拠
- ORDレコード
- ord-db1c140c7b3346bd82afd42fa84d251a
- 出典データセット
- uspto-grants-2013_03
- 特許番号
- US08404684B2
関連ノート
読み込み中…